Clinical Trials
Nanoform’s final clinical results confirm value proposition to the pharma industry
Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical s...
May 18, 2021 | News
Sanofi and GSK COVID-19 vaccine shows strong immunity in all age variants
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...
May 17, 2021 | News
Phebra's Confirm Bioequivalence of Oral and IV Formulations
Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP43...
May 14, 2021 | News
Merck’s Focus on Cancer
Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program Merck (NYSE: MR...
May 13, 2021 | News
Advancing gene therapy by solving challenges in scale-up & manufacturing
Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...
May 11, 2021 | Influencers
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
